Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benzoyl peroxide/tretinoin - Bausch Health Companies

Drug Profile

Benzoyl peroxide/tretinoin - Bausch Health Companies

Alternative Names: IDP-120

Latest Information Update: 17 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ortho Dermatologics
  • Developer Bausch Health Companies; Ortho Dermatologics
  • Class Anti-infectives; Antiacnes; Benzoic acids; Keratolytics; Oxidants; Peroxides; Retinoids; Skin disorder therapies; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Myeloid-derived suppressor cell modulators; Protein synthesis inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Acne vulgaris

Most Recent Events

  • 17 Oct 2021 Phase III development is ongoing in USA and Canada (Orth Dermatologics pipeline, October 2021)
  • 20 Aug 2020 Bausch Health Companies completes the phase III trial in Acne vulgaris (In Children, In adolescent, In Adults, In Elderly) in USA and Canada (Topical) (NCT03664752)
  • 23 Mar 2020 Bausch Health Companies completes a phase III clinical trial in Acne vulgaris (In adolescents, In children, In adults, In the elderly) in Canada and USA (Topical) (NCT03664739)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top